Advanced Search

 

Study ID Status Title Patient Level Data
FMS10018 Completed A study to assess the tolerance and effect on the hypothalamo-pituitary-adrenal axis of an increasing dose of oral fluticasone propionate.
FMS10019 Completed To Study Plasma Cortisol Levels After Single 1mg, 2mg and 4mg Night-time Doses of Inhaled Fluticasone Propionate and Beclomethasone Diproprionate
FMS10020 Completed The Systemic Effects of Inhaled Doses of 1mg, 2mg and 4mg Fluticasone Propionate Compared with Those of 1mg and 2mg Beclomethasone Dipropionate: A Pilot Study
FMS10021 Completed A comparison of the plasma level profiles and HPA axis suppressant activities of fluticasone propionate after inhalation of equivalent doses from aerosol and dry powder presentations
FMS10022 Completed A study to assess and compare the safety and plasma levels of repeated inhaled doses of fluticasone propionate (0.5mg, 1mg and 1.5mg daily) in comparison with placebo
FMS10023 Completed A study to investigate the bioequivalence of single 1mg doses of fluticasone propionate given in two different strengths of dry powder inhaler (Rotadisks™) – 250mcg and 500mcg blister
FMS10024 Completed A study to compare the effects of single night-time inhaled doses of fluticasone propionate (0.5, 1.0, 1.5 and 2.0mg) with beclomethasone dipropionate (1, 2, 3 and 4mg) on morning plasma cortisol levels
FMS10026 Completed A randomised, open label, 4-way cross-over study to assess the relative systemic pharmacokinetics and absolute bioavailability of single inhaled and intravenous doses of fluticasone propionate and mometasone furoate in healthy subjects Study Listed on ClinicalStudyDataRequest.com
FMS10030 Completed A repeat dose study of inhaled budesonide, FP and MF to assess drug accumulation in adipose tissue Study Listed on ClinicalStudyDataRequest.com
FMS10031 Completed Absolute Bioavailability of FP, BDP, and Budesonide following single inhaled 400mcg dose and assay limits of 50pg/mL. Study Listed on ClinicalStudyDataRequest.com
FMS10032 Completed A study to compare PK of a single doe of fluticasone propionate in healthy male Japanse and Caucasian subjects Study Listed on ClinicalStudyDataRequest.com
FMS10033 Completed A randomised, single-blind, placebo-controlled study with 5-way cross-over design to investigate the systemic pharmacokinetics and pharmacodynamics of single inhaled doses (800mcg and 1600mcg) of Fluticasone Propionate and Mometasone Furoate in healthy subjects. Study Listed on ClinicalStudyDataRequest.com
FMS30002 Completed A multi-centre, randomised, double-blind, parallel group study to validate the changes in tidal breathing lung function parameters versus FEV1 and PD20 assessments due to anti-inflammatory treatment in 5 to 10 years old mild to moderately symptomatic children with asthma.
FMS30019 Completed A single-blind, placebo-controlled, dose-ranging study to assess the effects of inhaled fluticasone propionate versus oral prednisone on the HPA-axis
FMS30024 Completed A phase III, multicentre, open-label, parallel-group study to compare the efficacy and tolerability offluticasone propionate 100 micrograms bd with budesonide 200 micrograms bd administered via a metered-dose inhaler in adult patients with mild to moderate asthma.
FMS30034 Completed A single-centre, placebo-controlled, randomised, double-blind, double-dummy, cross-over study to investigate longitudinal growth using knemometry in children with mild asthma during treatment with budesonide (200?g/ day and 400?g/ day) and fluticasone propionate (200?g/ day and 400?g/ day) as dr ...
FMS30035 Completed A Randomized, Double-Blind Comparative Trial of Three Dosage Regimens of Inhaled Fluticasone Propionate Versus Placebo in Adult Patients with Asthma
FMS30037 Completed A multi-centre, randomised, double-blind, double-dummy, parallel-group study to compare the efficacy and safety of fluticasone propionate 400mg daily with budesonide 400mg daily in children with asthma.
FMS30038 Completed A Multicentre, Double-Blind, Parallel-Group Study to Compare the Long-Term Efficacy and Safety of Fluticasone Propionate 750?g bd (1500?g Daily) with Beclomethasone Dipropionate 750?g bd (1500?g Daily) in Patients with Severe Asthma
FMS30039 Completed A Multicentre, Open 12-Month Study to Assess the Tolerance of Fluticasone Propionate Dry Powder Administered Via the Powder Inhaler at Doses Between 100?g bd (200?g/day) and 500?g bd (1000?g/day) in Adult Patients with Mild to Moderate Asthma
FMS30040 Completed A Multicentre, Open 12-Month Study to Assess the Tolerance of Fluticasone Propionate Administered Via the Pressurised Inhaler at Doses Between 100?g bd (200?g/day) and 500?g bd (1000?g/day) in Adult Patients with Mild to Moderate Asthma
FMS30041 Completed A Multicentre, Double-Blind, Randomised, Four-Week, Parallel-Group Study to Compare the Efficacy of, and Tolerance to, Fluticasone Propionate, 100?g bd (200?g/day), Administered Via the Metered-Dose Inhaler or as a Dry Powder Via the Diskhaler™ Inhaler in Adult Patients with Mild to Moderate Asthma
FMS30042 Completed A Multi-centre, Randomised, Double-Blind, Parallel-Group Study to Compare the Efficacy and Safety of Fluticasone Propionate 100?g bd (200?g Daily) Produced by Two Recrystallisation Processes (“Old Process” “New Process”) Administered Via Dry Powder Inhaler, and With “New Process” Fluticasone Pro ...
FMS30043 Completed A Multicentre, Double-Blind, Randomised, Four-Week, Parallel-Group Comparison of Fluticasone Propionate 100?g bd (200?g/day) with Beclomethasone Dipropionate 200?g bd (400?g/day) in Adult Patients with Mild to Moderate Asthma
FMS30044 Completed An Open Study to Assess the Long-Term Safety of Fluticasone Propionate 50?g bd (100?g/day) or 100?g bd (200?g/day) in Children, Aged 6-16 Years, with Moderately Severe Asthma

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.